OLANZAPINE

Product NDC
70518-2891
11-digit product format
705182891
Labeler code
70518
Product ID
70518-2891_d7855612-e84a-62ff-e053-2995a90a7a4b
Type
HUMAN PRESCRIPTION DRUG
Nonproprietary name
olanzapine
Dosage form
TABLET
Route
ORAL
Labeler
REMEDYREPACK INC.
Application
ANDA202050
Marketing category
ANDA
Marketing start
2020-09-17
Marketing end
0000-00-00
Substance
OLANZAPINE
Active strength
5 mg/1
Pharmacologic classes
Atypical Antipsychotic [EPC]
NDC exclude flag
No
Listing certified through
2023-12-31
Current FDA listing
Historical FDA.report record

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
70518-2891-02022-02-08C16284748780-1d6a99b39-c884-a426-e053-dadaa90af4c2e4574622-138a-4820-bcf5-6ab2558efdcf
70518-2891-02022-01-28C16284748780-1d6a99b39-c884-a426-e053-dadaa90af4c2e4574622-138a-4820-bcf5-6ab2558efdcf

Packages#

Package NDC, 11-digit format, Description table
Package NDC11-digit formatDescriptionUnitsMarketing startMarketing endSampleExclude flagStatus
70518-2891-07051828910030 TABLET in 1 BLISTER PACK (70518-2891-0) 30 tablet2020-09-170000-00-00NoNoCurrent